Bridgeway Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.5M Sell
78,000
-28,800
-27% -$567K 0.03% 607
2025
Q4
$2.02M Buy
106,800
+21,900
+26% +$406K 0.04% 534
2025
Q3
$1.58M Buy
+84,900
New +$1.59M 0.03% 608
2013
Q3
Sell
-54,900
Closed -$1.43M 1480
2013
Q2
$1.43M Buy
+54,900
New +$1.58M 0.06% 480

Other funds holding SBRA

Bridgeway Capital Management's SBRA Position: Q1 2026 in Review

Bridgeway Capital Management reduced its Sabra Healthcare REIT (SBRA) stake by 27% in Q1 2026, selling an estimated $567K and leaving 78,000 shares worth $1.5M. The position accounts for 0.03% of the portfolio, ranked #607.

Bridgeway Capital Management first reported a position in SBRA in Q2 2013 and has held it in 4 quarters since. The position peaked at $2.02M in Q4 2025. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Bridgeway Capital Management held 78,000 shares of Sabra Healthcare REIT worth $1.5M as of Q1 2026.
  • Bridgeway Capital Management sold 28,800 Sabra Healthcare REIT shares in Q1 2026, an estimated $567K.
  • Sabra Healthcare REIT made up 0.03% of Bridgeway Capital Management's portfolio in Q1 2026, its #607 holding.
  • Bridgeway Capital Management first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 4 quarters since.
  • Bridgeway Capital Management's Sabra Healthcare REIT position peaked at $2.02M in Q4 2025.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Bridgeway Capital Management's 13F filing for Q1 2026, filed 15 May 2026.